MEI Pharma, Inc. revenue for the last year amounted to 48.82 M USD, the most of which — 48.82 M USD — came from its highest performing source at the moment, Pharmaceutical Compounds, the year earlier bringing 40.70 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought MEI Pharma, Inc. 48.82 M USD, and the year before that — 40.70 M USD.